Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy

Colorectal cancer treatment has advanced over the past decade. The drug 5-fluorouracil is still used with a wide percentage of patients who do not respond. Therefore, a challenge is the identification of predictive biomarkers. The protein kinase R (PKR also called EIF2AK2) and its regulator, the non...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Ortega-García, María Belén, Mesa, Alberto, Moya, Elisa L.J., Rueda, Beatriz, Lopez-Ordoño, Gabriel, García, Javier Ángel, Conde, Verónica, Redondo-Cerezo, Eduardo, Lopez-Hidalgo, Javier Luis, Jiménez, Gema, Peran, Macarena, Martínez-González, Luis J., del Val, Coral, Zwir, Igor, Marchal, Juan Antonio, García, María Ángel
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072376/
https://ncbi.nlm.nih.gov/pubmed/32045987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados